- Published at
- by manilatimes.net
mixed
mixed
News for Epigenomics AG (EPGNY)
- Published at
- by globenewswire.com
mixedmixedCancer Biopsy Market to Reach USD 85.03 Billion by 2032, Driven by Rising Cancer Incidence and Advances in Liquid Biopsy Technologies
Increasing cases of cancer worldwide, investment in research and development, and continuous enhancement in biopsy technology are the factors responsible...- Published at
- by marketscreener.com
mixedmixedScibase : Presentation Board of directors AGM 2024
Presentation of the proposed board members to the Annual General Meeting on 13 May 2024 Jesper Høiland - born 1960, chairman Education:...- Published at
- by gurufocus.com
positivepositiveQ3 2022 Epigenomics AG Earnings Call Transcript
Nov 09, 2022 / 03:00PM GMTOperator Ladies and gentlemen, welcome to the Epigenomics AG conference call regarding the results of the first 9 months of 2022. (Ope- Published at
- by gurufocus.com
positivepositiveQ2 2022 Epigenomics AG Earnings Call Transcript
Aug 10, 2022 / 02:00PM GMTOperator Ladies and gentlemen, welcome to the Epigenomics Analyst and Investor Conference Call, regarding the half year results 2022.- Published at
- by gurufocus.com
positivepositiveQ1 2022 Epigenomics AG Earnings Call Transcript
May 11, 2022 / 02:00PM GMTOperator Ladies and gentlemen, welcome to the Epigenomics AG Conference Call regarding the results for Q1 2022. (Operator Instructions- Published at
- by gurufocus.com
positivepositiveQ4 2021 Epigenomics AG Earnings Call Transcript
Mar 24, 2022 / 03:00PM GMTOperator Ladies and gentlemen, welcome to today's conference call annual results 2021. (Operator Instructions) Let me now turn the flo- Published at
- by gurufocus.com
positivepositiveQ1 2021 Epigenomics AG Earnings Call Transcript
May 12, 2021 / 03:00PM GMTOperator Ladies and gentlemen, welcome to the Epigenomics AG's conference call regarding the results of the first quarter 2021. (Opera- Published at
- by gurufocus.com
positivepositiveEpigenomics AG - Special Call Transcript
Oct 20, 2020 / 02:00PM GMTOperator Ladies and gentlemen, hello, and welcome to the Epigenomics AG conference call regarding preliminary CMS decision. (Operator- Published at
- by gurufocus.com
positivepositiveQ2 2020 Epigenomics AG Earnings Call Transcript
Aug 13, 2020 / 02:00PM GMTOperator Good afternoon, ladies and gentlemen, and welcome to the Epigenomics AG's conference call regarding the half year results 202- Published at
- by gurufocus.com
positivepositiveEpigenomics AG - Special Call Transcript
Aug 11, 2020 / 01:30PM GMTOperator Good afternoon, ladies and gentlemen, and welcome to the Epigenomics AG Study Results Conference Call. (Operator Instructions- Published at
- by prnewswire.com
mixedmixedPrecision Medicine Takes Center Stage: Innovative Report Explores the Role of Companion Diagnostics in Transforming Healthcare
/PRNewswire/ -- The "Companion Diagnostic Markets - the Future of Diagnostics by Application, Technology and Funding With Executive and Consultant Guides...- Published at
- by globenewswire.com
mixedmixedColorectal Cancer Screening Market Size to Surpass USD 23.03 billion by 2030, exhibiting a CAGR of 4.4%
As per the report by Fortune Business Insights, the global Colorectal Cancer Screening Market size is projected to reach USD 23.03 billion in 2030, at a...- Published at
- by prnewswire.com
negativenegativeGlobal Colorectal Cancer (CRC) Screening Market Report 2023: Historical Data 2019-2022, Estimates for 2023, & Forecasts 2024-2029
/PRNewswire/ -- The "Global Colorectal Cancer (CRC) Screening Market (2023 Edition): Analysis by Screening Type, End-Use, By Region, By Country: Market...- Published at
- by prnewswire.com
mixedmixedGlobal Colorectal Cancer Screening Market Report 2023: Sector is Expected to Reach $9.73 Billion by 2033 at a CAGR of 15.94%
/PRNewswire/ -- The "Colorectal Cancer Screening Market - A Global and Regional Analysis: Focus on Technique, Sample Type, End User, and Country Analysis -...- Published at
- by prnewswire.com
neutralneutralIn-Vitro Colorectal Cancer Screening Tests Global Market Report 2023: Technological Advancements in Cancer Screening Techniques Presents Opportunities
/PRNewswire/ -- Research and Markets The "In-Vitro Colorectal Cancer Screening Tests - Global Strategic Business Report" report has been added to...- Published at
- by prnewswire.com
mixedmixedWorldwide In Vitro Diagnostic Tests Market Report 2022: COVID-19 Impacts, Summary, Regions of Market Influence, and What to Watch For Long-Term
/PRNewswire/ -- The- Published at
- by prnewswire.com
mixedmixedWorldwide In Vitro Diagnostic Tests Market Report 2021 with 200+ Company profiles
/PRNewswire/ -- TheTMO.MXTMOSSMXYSSMXFQDEL.MXQDELBMRABDXBBDX.MXBDXAXDX.MXAXDXANPCYANPCFAGL.L6869.T300685.SZ0R19.L0R0H.L0H8E.L0A55.LVNRXTRIBTECHT1CH34.SARNVAWRNVADRNVAQIAN.MXQIA.DEQGENPKIP1KI34.SAOPGNNMRDMYGNMYD.DEHOLX.MXHOLXHO1.DEH1OL34.SAGRFSGRFPN.MXGRF.MCGIKLYGIFOFGIFLFGH.MXGHFMIERBEPGNYEPGNFEKF.LEKDHFECX.DEDSRLFDIA.MICDNABUWA.DEBRKR.MXBRKRBIOCBIO-BBIO4549.T0KHE.L0K3W.L0J5Q.L0A8L.LVIVOVCYTMDTN.MXMDT.BAMDTLMNXDXCM.MXDXCMDHR.MXDHRDHER34.SADC4.DEDAP.DED1EX34.SACERS2M6.DE0Y6X.L0R2B.L0K0K.L0A4M.L- Published at
- by thestreet.com
mixedmixedWorldwide Next-Generation Sequencing Industry To 2025 - Key Drivers And Trends
DUBLIN, June 14, 2021 /PRNewswire/ -- The "Next-Generation Sequencing: Emerging Clinical Applications and Global Markets 2020-2025" report has been added toILU.DEILMN.MXILMNI1LM34.SAHTGMGH.MXGH0J8Z.LYGEN.LTMO.MXTMOTKBIFRYLPFROGN.MXROG.SWRO.SWRHHVFRHHBYRHHBFPSNLPHIAN.MXPHIA.DEPHIA.ASPHI1.DEPHG.BAPHGPACBONC.LNTRANSTGMYGNMYD.DEIDXGIDGGWFLGT.MXFLGTEPGNYEPGNFECX.DECGIXCDNAA1GI34.SAA.MXA688315.SS4974.T0TDF.L0R0H.L0QQ6.L0K3W.L0HAV.L084650.KQ038290.KQBIOCBDSXANPCYANPCFAGL.L300685.SZ000710.SZ- Published at
- by prnewswire.com
mixedmixedWorldwide Next-Generation Sequencing Industry to 2025 - Key Drivers and Trends
/PRNewswire/ -- TheILU.DEILMN.MXILMNI1LM34.SAHTGMGH.MXGH0J8Z.LYGEN.LTMO.MXTMOTKBIFRYLPFROGN.MXROG.SWRO.SWRHHVFRHHBYRHHBFPSNLPHIAN.MXPHIA.DEPHIA.ASPHI1.DEPHG.BAPHGPACBONC.LNTRANSTGMYGNMYD.DEIDXGIDGGWFLGT.MXFLGTEPGNYEPGNFECX.DECGIXCDNAA1GI34.SAA.MXA688315.SS4974.T0TDF.L0R0H.L0QQ6.L0K3W.L0HAV.L084650.KQ038290.KQBIOCBDSXANPCYANPCFAGL.L300685.SZ000710.SZ